Kevin Soares
Hepatopancreatobiliary Fellowship Program Director · New York Presbyterian Hospital
Credentials: · · · · · ·
History
PresentHepatopancreatobiliary Fellowship · New York Presbyterian Hospital

Research
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature · 2023 · 1,126 citations
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Science Translational Medicine · 2015 · 626 citations
Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation
Cancer Immunology Research · 2014 · 468 citations
- WJ
99 papers
- AW
90 papers
- MD
89 papers
- PK
85 papers
- JD
81 papers

78 papers
- EO
33 papers
- AC
24 papers
Clinical trials
- 2026–2028
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
- 2024–2030
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
- 2025
